CSE-1034 versus Ceftriaxone: Efficacy and Safety Analysis from a Randomized, Open-labeled Phase III Study in Complicated Urinary Tract Infections. | J Glob Infect Dis;10(4): 188-195, 2018. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

CSE-1034 versus Ceftriaxone: Efficacy and Safety Analysis from a Randomized, Open-labeled Phase III Study in Complicated Urinary Tract Infections.

Chaudhary, Manu; Ayub, Shiekh Gazalla; Mir, Mohd Amin.

Affiliation

Chaudhary M; Department of Clinical Research, Venus Remedies, Panchkula, Haryana, India.
Ayub SG; Department of Clinical Research, Venus Remedies, Panchkula, Haryana, India.
Mir MA; Department of Clinical Research, Venus Remedies, Panchkula, Haryana, India.

J Glob Infect Dis ; 10(4): 188-195, 2018.

Article in En | MEDLINE | ID: mdl-30581259

Key words

CSE-1034; Ceftriaxone; anti-microbial resistance; cUTI

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: J Glob Infect Dis Year: 2018 Document type: Article Affiliation country: India Country of publication: India

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: J Glob Infect Dis Year: 2018 Document type: Article Affiliation country: India Country of publication: India